breast cancer

News

"Tokyo, Japan - May 11, 2012: Pfizer building on May 11, 2012 in Tokyo. Pfizer is one of largest pharmaceutical companies worldwide with tremendous revenue $67.4 bn USD for 2011. It exists since 1849."

Ibrance trial failure dashes Pfizer’s growth hopes for the d...

Pfizer already makes big revenues from its breast cancer drug Ibrance, but a late-stage trial failure has set back its hopes of even loftier sales – and set up a challenge from Eli Lilly’s

News

NICE’s track record in cancer drugs: the impact of the CDF and the role of interim funding

Immunomedics wows ESMO with breast cancer data reveal

Immunomedics has revealed the trial data that convinced Gilead to stage a

Views & Analysis

Giving the forgotten generation of cancer patients a voice

Young people with cancer need a “seat at the table”, but instead they are often side-lined and voiceless.

News

Merck & Co signs multi-billion cancer drug development deal ...

Merck & Co has signed a multi-billion cancer drug development deal, which will see it investing $1 billion in partner Seattle Genetics.

News

UK medical journals spar over breast cancer screening study

Screening women for breast cancer in their 40s rather than their 50s could save lives, say the authors of a new Lancet Oncology study, although that finding has been challenged

News